<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1995-11-01" modified="2020-10-07" version="219">
<accession>P46527</accession>
<accession>Q16307</accession>
<accession>Q5U0H2</accession>
<accession>Q9BUS6</accession>
<name>CDN1B_HUMAN</name>
<protein>
<recommendedName>
<fullName>Cyclin-dependent kinase inhibitor 1B</fullName>
</recommendedName>
<alternativeName>
<fullName evidence="37">Cyclin-dependent kinase inhibitor p27</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="38">p27Kip1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">CDKN1B</name>
<name type="synonym">KIP1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1994" name="Cell" volume="78" first="59" last="66">
<title>Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.</title>
<authorList>
<person name="Polyak K."/>
<person name="Lee M.-H."/>
<person name="Erdjument-Bromage H."/>
<person name="Koff A."/>
<person name="Roberts J.M."/>
<person name="Tempst P."/>
<person name="Massague J."/>
</authorList>
<dbReference type="PubMed" id="8033212"/>
<dbReference type="DOI" id="10.1016/0092-8674(94)90572-x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>PROTEIN SEQUENCE OF 28-79 AND 104-152</scope>
<source>
<tissue>Kidney</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1995" name="Cancer Res." volume="55" first="1206" last="1210">
<title>Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias.</title>
<authorList>
<person name="Pietenpol J.A."/>
<person name="Bohlander S.K."/>
<person name="Sato Y."/>
<person name="Papadopoulos N."/>
<person name="Liu B."/>
<person name="Friedman C."/>
<person name="Trask B.J."/>
<person name="Roberts J.M."/>
<person name="Kinzler K.W."/>
<person name="Rowley J.D."/>
</authorList>
<dbReference type="PubMed" id="7882309"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="submission" date="2004-10" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT GLY-109</scope>
</reference>
<reference key="4">
<citation type="submission" date="2002-02" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS TRP-15 AND GLY-109</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT GLY-109</scope>
<source>
<tissue>Cervix</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1999" name="Genes Dev." volume="13" first="1181" last="1189">
<title>Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation.</title>
<authorList>
<person name="Montagnoli A."/>
<person name="Fiore F."/>
<person name="Eytan E."/>
<person name="Carrano A.C."/>
<person name="Draetta G.F."/>
<person name="Hershko A."/>
<person name="Pagano M."/>
</authorList>
<dbReference type="PubMed" id="10323868"/>
<dbReference type="DOI" id="10.1101/gad.13.9.1181"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>PHOSPHORYLATION AT THR-187</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="25146" last="25154">
<title>Phosphorylation at serine 10, a major phosphorylation site of p27(Kip1), increases its protein stability.</title>
<authorList>
<person name="Ishida N."/>
<person name="Kitagawa M."/>
<person name="Hatakeyama S."/>
<person name="Nakayama K."/>
</authorList>
<dbReference type="PubMed" id="10831586"/>
<dbReference type="DOI" id="10.1074/jbc.m001144200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-10</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2002" name="EMBO J." volume="21" first="3390" last="3401">
<title>A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression.</title>
<authorList>
<person name="Boehm M."/>
<person name="Yoshimoto T."/>
<person name="Crook M.F."/>
<person name="Nallamshetty S."/>
<person name="True A."/>
<person name="Nabel G.J."/>
<person name="Nabel E.G."/>
</authorList>
<dbReference type="PubMed" id="12093740"/>
<dbReference type="DOI" id="10.1093/emboj/cdf343"/>
</citation>
<scope>INTERACTION WITH UHMK1</scope>
<scope>PHOSPHORYLATION AT SER-10</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF SER-10 AND THR-187</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="28706" last="28713">
<title>Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization.</title>
<authorList>
<person name="Fujita N."/>
<person name="Sato S."/>
<person name="Katayama K."/>
<person name="Tsuruo T."/>
</authorList>
<dbReference type="PubMed" id="12042314"/>
<dbReference type="DOI" id="10.1074/jbc.m203668200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-10; THR-187 AND THR-198</scope>
<scope>INTERACTION WITH AKT1 AND YWHAQ</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF SER-10; THR-157; THR-187 AND THR-198</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2002" name="Nat. Med." volume="8" first="1136" last="1144">
<title>Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer.</title>
<authorList>
<person name="Viglietto G."/>
<person name="Motti M.L."/>
<person name="Bruni P."/>
<person name="Melillo R.M."/>
<person name="D'Alessio A."/>
<person name="Califano D."/>
<person name="Vinci F."/>
<person name="Chiappetta G."/>
<person name="Tsichlis P."/>
<person name="Bellacosa A."/>
<person name="Fusco A."/>
<person name="Santoro M."/>
</authorList>
<dbReference type="PubMed" id="12244303"/>
<dbReference type="DOI" id="10.1038/nm762"/>
</citation>
<scope>PHOSPHORYLATION AT THR-157</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>ASSOCIATION WITH BREAST CANCER</scope>
<scope>MUTAGENESIS OF THR-157</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2002" name="Nat. Med." volume="8" first="1145" last="1152">
<title>PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.</title>
<authorList>
<person name="Shin I."/>
<person name="Yakes F.M."/>
<person name="Rojo F."/>
<person name="Shin N.-Y."/>
<person name="Bakin A.V."/>
<person name="Baselga J."/>
<person name="Arteaga C.L."/>
</authorList>
<dbReference type="PubMed" id="12244301"/>
<dbReference type="DOI" id="10.1038/nm759"/>
</citation>
<scope>PHOSPHORYLATION AT THR-157</scope>
<scope>INTERACTION WITH AKT1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF THR-157; SER-161 AND THR-162</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="49254" last="49260">
<title>Phosphorylation of p27Kip1 at threonine 198 by p90 ribosomal protein S6 kinases promotes its binding to 14-3-3 and cytoplasmic localization.</title>
<authorList>
<person name="Fujita N."/>
<person name="Sato S."/>
<person name="Tsuruo T."/>
</authorList>
<dbReference type="PubMed" id="14504289"/>
<dbReference type="DOI" id="10.1074/jbc.m306614200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-10 AND THR-198</scope>
<scope>INTERACTION WITH YWHAE; YWHAH; SFN; YWHAQ; RPS6KA1 AND RPS6KA3</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF THR-157 AND THR-198</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="Mol. Biol. Cell" volume="14" first="3664" last="3674">
<title>Spy1 interacts with p27Kip1 to allow G1/S progression.</title>
<authorList>
<person name="Porter L.A."/>
<person name="Kong-Beltran M."/>
<person name="Donoghue D.J."/>
</authorList>
<dbReference type="PubMed" id="12972555"/>
<dbReference type="DOI" id="10.1091/mbc.e02-12-0820"/>
</citation>
<scope>INTERACTION WITH SPDYA</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2004" name="Cell Cycle" volume="3" first="1074" last="1080">
<title>Akt-dependent T198 phosphorylation of cyclin-dependent kinase inhibitor p27kip1 in breast cancer.</title>
<authorList>
<person name="Motti M.L."/>
<person name="De Marco C."/>
<person name="Califano D."/>
<person name="Fusco A."/>
<person name="Viglietto G."/>
</authorList>
<dbReference type="PubMed" id="15280662"/>
</citation>
<scope>PHOSPHORYLATION AT THR-198</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF SER-10; THR-157; THR-187 AND THR-198</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2005" name="Nat. Cell Biol." volume="7" first="831" last="836">
<title>Cdc2-cyclin E complexes regulate the G1/S phase transition.</title>
<authorList>
<person name="Aleem E."/>
<person name="Kiyokawa H."/>
<person name="Kaldis P."/>
</authorList>
<dbReference type="PubMed" id="16007079"/>
<dbReference type="DOI" id="10.1038/ncb1284"/>
</citation>
<scope>INTERACTION WITH CDK1</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="Blood" volume="107" first="1133" last="1140">
<title>Tyrosine phosphorylation modulates binding preference to cyclin-dependent kinases and subcellular localization of p27Kip1 in the acute promyelocytic leukemia cell line NB4.</title>
<authorList>
<person name="Kardinal C."/>
<person name="Dangers M."/>
<person name="Kardinal A."/>
<person name="Koch A."/>
<person name="Brandt D.T."/>
<person name="Tamura T."/>
<person name="Welte K."/>
</authorList>
<dbReference type="PubMed" id="16195327"/>
<dbReference type="DOI" id="10.1182/blood-2005-05-1771"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-88 AND TYR-89</scope>
<scope>DEPHOSPHORYLATION</scope>
<scope>INTERACTION WITH GRB2; CDK2 AND CDK4</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF TYR-74; TYR-88 AND TYR-89</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2006" name="Mol. Cell. Biol." volume="26" first="5070" last="5085">
<title>Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK 'inhibitors'.</title>
<authorList>
<person name="Bockstaele L."/>
<person name="Kooken H."/>
<person name="Libert F."/>
<person name="Paternot S."/>
<person name="Dumont J.E."/>
<person name="de Launoit Y."/>
<person name="Roger P.P."/>
<person name="Coulonval K."/>
</authorList>
<dbReference type="PubMed" id="16782892"/>
<dbReference type="DOI" id="10.1128/mcb.02006-05"/>
</citation>
<scope>INTERACTION WITH CDK4</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2006" name="Mol. Cell. Biol." volume="26" first="5994" last="6004">
<title>Regulation of p27 degradation and S-phase progression by Ro52 RING finger protein.</title>
<authorList>
<person name="Sabile A."/>
<person name="Meyer A.M."/>
<person name="Wirbelauer C."/>
<person name="Hess D."/>
<person name="Kogel U."/>
<person name="Scheffner M."/>
<person name="Krek W."/>
</authorList>
<dbReference type="PubMed" id="16880511"/>
<dbReference type="DOI" id="10.1128/mcb.01630-05"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF THR-187</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="15558" last="15563">
<title>Germ-line mutations in p27(Kip1) cause a multiple endocrine neoplasia syndrome in rats and humans.</title>
<authorList>
<person name="Pellegata N.S."/>
<person name="Quintanilla-Martinez L."/>
<person name="Siggelkow H."/>
<person name="Samson E."/>
<person name="Bink K."/>
<person name="Hoefler H."/>
<person name="Fend F."/>
<person name="Graw J."/>
<person name="Atkinson M.J."/>
</authorList>
<dbReference type="PubMed" id="17030811"/>
<dbReference type="DOI" id="10.1073/pnas.0603877103"/>
</citation>
<scope>INVOLVEMENT IN MEN4</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2007" name="Cell" volume="128" first="281" last="294">
<title>p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2.</title>
<authorList>
<person name="Chu I."/>
<person name="Sun J."/>
<person name="Arnaout A."/>
<person name="Kahn H."/>
<person name="Hanna W."/>
<person name="Narod S."/>
<person name="Sun P."/>
<person name="Tan C.K."/>
<person name="Hengst L."/>
<person name="Slingerland J."/>
</authorList>
<dbReference type="PubMed" id="17254967"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.11.049"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-74 AND TYR-88 BY SRC</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
<title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Smogorzewska A."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K.E."/>
<person name="Luo J."/>
<person name="Bakalarski C.E."/>
<person name="Zhao Z."/>
<person name="Solimini N."/>
<person name="Lerenthal Y."/>
<person name="Shiloh Y."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525332"/>
<dbReference type="DOI" id="10.1126/science.1140321"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2008" name="Cancer Res." volume="68" first="5076" last="5085">
<title>Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels.</title>
<authorList>
<person name="Morishita D."/>
<person name="Katayama R."/>
<person name="Sekimizu K."/>
<person name="Tsuruo T."/>
<person name="Fujita N."/>
</authorList>
<dbReference type="PubMed" id="18593906"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-08-0634"/>
</citation>
<scope>INTERACTION WITH PIM1</scope>
<scope>PHOSPHORYLATION AT THR-157 AND THR-198</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Mol. Cell. Biol." volume="29" first="986" last="999">
<title>p27Kip1 inhibits cyclin D-cyclin-dependent kinase 4 by two independent modes.</title>
<authorList>
<person name="Ray A."/>
<person name="James M.K."/>
<person name="Larochelle S."/>
<person name="Fisher R.P."/>
<person name="Blain S.W."/>
</authorList>
<dbReference type="PubMed" id="19075005"/>
<dbReference type="DOI" id="10.1128/mcb.00898-08"/>
</citation>
<scope>INTERACTION WITH CDK4</scope>
<scope>PHOSPHORYLATION</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF TYR-74; TYR-88 AND TYR-89</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2011" name="Cancer Discov." volume="1" first="326" last="337">
<title>PPM1H is a p27 phosphatase implicated in trastuzumab resistance.</title>
<authorList>
<person name="Lee-Hoeflich S.T."/>
<person name="Pham T.Q."/>
<person name="Dowbenko D."/>
<person name="Munroe X."/>
<person name="Lee J."/>
<person name="Li L."/>
<person name="Zhou W."/>
<person name="Haverty P.M."/>
<person name="Pujara K."/>
<person name="Stinson J."/>
<person name="Chan S.M."/>
<person name="Eastham-Anderson J."/>
<person name="Pandita A."/>
<person name="Seshagiri S."/>
<person name="Hoeflich K.P."/>
<person name="Turashvili G."/>
<person name="Gelmon K.A."/>
<person name="Aparicio S.A."/>
<person name="Davis D.P."/>
<person name="Sliwkowski M.X."/>
<person name="Stern H.M."/>
</authorList>
<dbReference type="PubMed" id="22586611"/>
<dbReference type="DOI" id="10.1158/2159-8290.cd-11-0062"/>
</citation>
<scope>DEPHOSPHORYLATION BY PPM1H AT THR-187</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2011" name="Oncogene" volume="30" first="3502" last="3512">
<title>Phosphorylation of p27Kip1 by JAK2 directly links cytokine receptor signaling to cell cycle control.</title>
<authorList>
<person name="Jakel H."/>
<person name="Weinl C."/>
<person name="Hengst L."/>
</authorList>
<dbReference type="PubMed" id="21423214"/>
<dbReference type="DOI" id="10.1038/onc.2011.68"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-88 BY JAK2</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2013" name="Cell. Signal." volume="25" first="2047" last="2059">
<title>Fbxl12 triggers G1 arrest by mediating degradation of calmodulin kinase I.</title>
<authorList>
<person name="Mallampalli R.K."/>
<person name="Kaercher L."/>
<person name="Snavely C."/>
<person name="Pulijala R."/>
<person name="Chen B.B."/>
<person name="Coon T."/>
<person name="Zhao J."/>
<person name="Agassandian M."/>
</authorList>
<dbReference type="PubMed" id="23707388"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2013.05.012"/>
</citation>
<scope>PHOSPHORYLATION AT THR-157 AND THR-198 BY CAMK1</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="28">
<citation type="journal article" date="2013" name="Mol. Cell" volume="49" first="1159" last="1166">
<title>Regulation of the CRL4(Cdt2) ubiquitin ligase and cell-cycle exit by the SCF(Fbxo11) ubiquitin ligase.</title>
<authorList>
<person name="Rossi M."/>
<person name="Duan S."/>
<person name="Jeong Y.T."/>
<person name="Horn M."/>
<person name="Saraf A."/>
<person name="Florens L."/>
<person name="Washburn M.P."/>
<person name="Antebi A."/>
<person name="Pagano M."/>
</authorList>
<dbReference type="PubMed" id="23478441"/>
<dbReference type="DOI" id="10.1016/j.molcel.2013.02.004"/>
</citation>
<scope>PHOSPHORYLATION AT THR-187 BY CDK1 AND CDK2</scope>
</reference>
<reference key="29">
<citation type="journal article" date="1996" name="Nature" volume="382" first="325" last="331">
<title>Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex.</title>
<authorList>
<person name="Russo A.A."/>
<person name="Jeffrey P.D."/>
<person name="Patten A.K."/>
<person name="Massague J."/>
<person name="Pavletich N.P."/>
</authorList>
<dbReference type="PubMed" id="8684460"/>
<dbReference type="DOI" id="10.1038/382325a0"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 23-106 IN COMPLEX WITH CCNA2 AND CDK2</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2005" name="Mol. Cell" volume="20" first="9" last="19">
<title>Structural basis of the Cks1-dependent recognition of p27(Kip1) by the SCF(Skp2) ubiquitin ligase.</title>
<authorList>
<person name="Hao B."/>
<person name="Zheng N."/>
<person name="Schulman B.A."/>
<person name="Wu G."/>
<person name="Miller J.J."/>
<person name="Pagano M."/>
<person name="Pavletich N.P."/>
</authorList>
<dbReference type="PubMed" id="16209941"/>
<dbReference type="DOI" id="10.1016/j.molcel.2005.09.003"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 181-190 IN COMPLEX WITH SKP1; SKP2 AND CKS1B</scope>
<scope>PHOSPHORYLATION AT THR-187</scope>
<scope>MUTAGENESIS OF GLU-185 AND THR-187</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2007" name="Cell" volume="128" first="269" last="280">
<title>Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases.</title>
<authorList>
<person name="Grimmler M."/>
<person name="Wang Y."/>
<person name="Mund T."/>
<person name="Cilensek Z."/>
<person name="Keidel E.-M."/>
<person name="Waddell M.B."/>
<person name="Jaekel H."/>
<person name="Kullmann M."/>
<person name="Kriwacki R.W."/>
<person name="Hengst L."/>
</authorList>
<dbReference type="PubMed" id="17254966"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.11.047"/>
</citation>
<scope>STRUCTURE BY NMR OF 22-104</scope>
<scope>PHOSPHORYLATION AT TYR-88</scope>
<scope>FUNCTION</scope>
<scope>INDUCTION</scope>
<scope>INTERACTION WITH LYN</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>MUTAGENESIS OF TYR-88 AND TYR-89</scope>
</reference>
<reference key="32" evidence="2">
<citation type="journal article" date="2017" name="EMBO J." volume="36" first="2251" last="2262">
<title>Structural basis of divergent cyclin-dependent kinase activation by Spy1/RINGO proteins.</title>
<authorList>
<person name="McGrath D.A."/>
<person name="Fifield B.A."/>
<person name="Marceau A.H."/>
<person name="Tripathi S."/>
<person name="Porter L.A."/>
<person name="Rubin S.M."/>
</authorList>
<dbReference type="PubMed" id="28666995"/>
<dbReference type="DOI" id="10.15252/embj.201796905"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.60 ANGSTROMS) IN COMPLEX WITH CDK2 AND SPDYA</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2010" name="Hum. Mutat." volume="31" first="E1825" last="E1835">
<title>A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization.</title>
<authorList>
<person name="Molatore S."/>
<person name="Marinoni I."/>
<person name="Lee M."/>
<person name="Pulz E."/>
<person name="Ambrosio M.R."/>
<person name="degli Uberti E.C."/>
<person name="Zatelli M.C."/>
<person name="Pellegata N.S."/>
</authorList>
<dbReference type="PubMed" id="20824794"/>
<dbReference type="DOI" id="10.1002/humu.21354"/>
</citation>
<scope>VARIANT LEU-69</scope>
<scope>CHARACTERIZATION OF VARIANT LEU-69</scope>
</reference>
<comment type="function">
<text evidence="9 12 21 24 27 33">Important regulator of cell cycle progression. Inhibits the kinase activity of CDK2 bound to cyclin A, but has little inhibitory activity on CDK2 bound to SPDYA (PubMed:28666995). Involved in G1 arrest. Potent inhibitor of cyclin E- and cyclin A-CDK2 complexes. Forms a complex with cyclin type D-CDK4 complexes and is involved in the assembly, stability, and modulation of CCND1-CDK4 complex activation. Acts either as an inhibitor or an activator of cyclin type D-CDK4 complexes depending on its phosphorylation state and/or stoichometry.</text>
</comment>
<comment type="subunit">
<text evidence="5 10 11 12 14 15 18 19 20 21 24 26 27 30 33 34">Forms a ternary complex composed of CCNE1, CDK2 and CDKN1B. Interacts directly with CCNE1; the interaction is inhibited by CDK2-dependent phosphorylation on Thr-187. Interacts with COPS5, subunit of the COP9 signalosome complex; the interaction leads to CDKN1B degradation. Interacts with NUP50; the interaction leads to nuclear import and degradation of phosphorylated CDKN1B. Interacts with CCND1 and SNX6 (By similarity). Interacts (Thr-198-phosphorylated form) with 14-3-3 proteins, binds strongly YWHAQ, weakly YWHAE and YWHAH, but not YWHAB nor YWHAZ; the interaction with YWHAQ results in translocation to the cytoplasm (PubMed:14504289). Interacts with AKT1 and LYN; the interactions lead to cytoplasmic mislocation, phosphorylation of CDKN1B and inhibition of cell cycle arrest (PubMed:12042314, PubMed:12244301, PubMed:17254966). Forms a ternary complex with CCNA2 and CDK2; CDKN1B inhibits the kinase activity of CDK2 through conformational rearrangements. Interacts (unphosphorylated form) with CDK2. Forms a complex with CDK2 and SPDYA, but does not directly interact with SPDYA (PubMed:12972555, PubMed:28666995). Forms a ternary complex composed of cyclin D, CDK4 and CDKN1B. Interacts (phosphorylated on Tyr-88 and Tyr-89) with CDK4; the interaction is required for cyclin D and CDK4 complex assembly, induces nuclear translocation and activates the CDK4 kinase activity. Interacts with GRB2 (PubMed:16195327). Interacts with PIM1 (PubMed:18593906). Identified in a complex with SKP1, SKP2 and CKS1B (PubMed:16209941). Interacts with UHMK1; the interaction leads to cytoplasmic mislocation, phosphorylation of CDKN1B and inhibition of cell cycle arrest (PubMed:12093740). Interacts also with CDK1 (PubMed:16007079). Dephosphorylated on Thr-187 by PPM1H, leading to CDKN1B stability (PubMed:22586611).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-11524452">
<id>Q8N9N5-2</id>
<label>BANP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-375065">
<id>P78396</id>
<label>CCNA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-457097">
<id>P20248</id>
<label>CCNA2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>17</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-495332">
<id>P14635</id>
<label>CCNB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-375001">
<id>P24385</id>
<label>CCND1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-748789">
<id>P30279</id>
<label>CCND2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-519526">
<id>P24864</id>
<label>CCNE1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-375033">
<id>O96020</id>
<label>CCNE2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-375096">
<id>P24941</id>
<label>CDK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>25</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-295644">
<id>P11802</id>
<label>CDK4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-1041567">
<id>Q00535</id>
<label>CDK5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-295663">
<id>Q00534</id>
<label>CDK6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-81249">
<id>O15111</id>
<label>CHUK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-594661">
<id>Q92905</id>
<label>COPS5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-359390">
<id>Q13616</id>
<label>CUL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-358297">
<id>O00505</id>
<label>KPNA3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-540602">
<id>O15131</id>
<label>KPNA5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-79452">
<id>P07948</id>
<label>LYN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-355924">
<id>P33993</id>
<label>MCM7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-11522433">
<id>Q5JR59-3</id>
<label>MTUS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-1018629">
<id>P11309-1</id>
<label>PIM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-446668">
<id>P61586</id>
<label>RHOA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-963034">
<id>Q15418</id>
<label>RPS6KA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-16087037">
<id>Q9UQR0-1</id>
<label>SCML2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-456291">
<id>Q13309</id>
<label>SKP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-7125479">
<id>Q5MJ70</id>
<label>SPDYA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-445909">
<id>P16949</id>
<label>STMN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-741515">
<id>Q9NVV9</id>
<label>THAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-355744">
<id>Q12933</id>
<label>TRAF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-914519">
<id>P00520</id>
<label>Abl1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-519280">
<id>P46527</id>
</interactant>
<interactant intactId="EBI-646604">
<id>Q62120</id>
<label>Jak2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="5">Endosome</location>
</subcellularLocation>
<text evidence="5">Nuclear and cytoplasmic in quiescent cells. AKT- or RSK-mediated phosphorylation on Thr-198, binds 14-3-3, translocates to the cytoplasm and promotes cell cycle progression. Mitogen-activated UHMK1 phosphorylation on Ser-10 also results in translocation to the cytoplasm and cell cycle progression. Phosphorylation on Ser-10 facilitates nuclear export. Translocates to the nucleus on phosphorylation of Tyr-88 and Tyr-89. Colocalizes at the endosome with SNX6; this leads to lysosomal degradation (By similarity).</text>
</comment>
<comment type="tissue specificity">
<text>Expressed in all tissues tested. Highest levels in skeletal muscle, lowest in liver and kidney.</text>
</comment>
<comment type="induction">
<text evidence="24">Maximal levels in quiescence cells and early G(1). Levels decrease after mitogen stimulation as cells progress toward S-phase.</text>
</comment>
<comment type="domain">
<text>A peptide sequence containing only AA 28-79 retains substantial Kip1 cyclin A/CDK2 inhibitory activity.</text>
</comment>
<comment type="PTM">
<text evidence="8 9 10 11 15 16 19 20 24 25 26 29 31 32">Phosphorylated; phosphorylation occurs on serine, threonine and tyrosine residues. Phosphorylation on Ser-10 is the major site of phosphorylation in resting cells, takes place at the G(0)-G(1) phase and leads to protein stability. Phosphorylation on other sites is greatly enhanced by mitogens, growth factors, cMYC and in certain cancer cell lines. The phosphorylated form found in the cytoplasm is inactivate. Phosphorylation on Thr-198 is required for interaction with 14-3-3 proteins. Phosphorylation on Thr-187, by CDK1 and CDK2 leads to protein ubiquitination and proteasomal degradation. Tyrosine phosphorylation promotes this process. Phosphorylation by PKB/AKT1 can be suppressed by LY294002, an inhibitor of the catalytic subunit of PI3K. Phosphorylation on Tyr-88 and Tyr-89 has no effect on binding CDK2, but is required for binding CDK4. Dephosphorylated on tyrosine residues by G-CSF.</text>
</comment>
<comment type="PTM">
<text evidence="8 10 20 31">Ubiquitinated; in the cytoplasm by the KPC complex (composed of RNF123/KPC1 and UBAC1/KPC2) and, in the nucleus, by SCF(SKP2). The latter requires prior phosphorylation on Thr-187. Ubiquitinated; by a TRIM21-containing SCF(SKP2)-like complex; leads to its degradation.</text>
</comment>
<comment type="PTM">
<text evidence="5">Subject to degradation in the lysosome. Interaction with SNX6 promotes lysosomal degradation (By similarity).</text>
</comment>
<comment type="disease" evidence="23">
<disease id="DI-02004">
<name>Multiple endocrine neoplasia 4</name>
<acronym>MEN4</acronym>
<description>Multiple endocrine neoplasia (MEN) syndromes are inherited cancer syndromes of the thyroid. MEN4 is a MEN-like syndrome with a phenotypic overlap of both MEN1 and MEN2.</description>
<dbReference type="MIM" id="610755"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>Decreased levels of p27Kip1, mainly due to proteasomal degradation, are found in various epithelial tumors originating from lung, breast, colon, ovary, esophagus, thyroid and prostate.</text>
</comment>
<comment type="similarity">
<text evidence="39">Belongs to the CDI family.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/CDKN1BID116.html"/>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/cdkn1b/"/>
</comment>
<dbReference type="EMBL" id="U10906">
<property type="protein sequence ID" value="AAA20240.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S76988">
<property type="protein sequence ID" value="AAD14244.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S76986">
<property type="protein sequence ID" value="AAD14244.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BT019553">
<property type="protein sequence ID" value="AAV38360.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BT019554">
<property type="protein sequence ID" value="AAV38361.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF480891">
<property type="protein sequence ID" value="AAL78041.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC001971">
<property type="protein sequence ID" value="AAH01971.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS8653.1"/>
<dbReference type="RefSeq" id="NP_004055.1">
<property type="nucleotide sequence ID" value="NM_004064.4"/>
</dbReference>
<dbReference type="PDB" id="1H27">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="E=25-35"/>
</dbReference>
<dbReference type="PDB" id="1JSU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="C=23-106"/>
</dbReference>
<dbReference type="PDB" id="2AST">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="D=181-190"/>
</dbReference>
<dbReference type="PDB" id="5UQ3">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.60"/>
<property type="chains" value="C=1-198"/>
</dbReference>
<dbReference type="PDB" id="6ATH">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.82"/>
<property type="chains" value="C=22-85"/>
</dbReference>
<dbReference type="PDB" id="6P8E">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="C=25-93"/>
</dbReference>
<dbReference type="PDB" id="6P8F">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.89"/>
<property type="chains" value="C=25-106"/>
</dbReference>
<dbReference type="PDB" id="6P8G">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="C=25-93"/>
</dbReference>
<dbReference type="PDBsum" id="1H27"/>
<dbReference type="PDBsum" id="1JSU"/>
<dbReference type="PDBsum" id="2AST"/>
<dbReference type="PDBsum" id="5UQ3"/>
<dbReference type="PDBsum" id="6ATH"/>
<dbReference type="PDBsum" id="6P8E"/>
<dbReference type="PDBsum" id="6P8F"/>
<dbReference type="PDBsum" id="6P8G"/>
<dbReference type="BMRB" id="P46527"/>
<dbReference type="SMR" id="P46527"/>
<dbReference type="BioGRID" id="107461">
<property type="interactions" value="100"/>
</dbReference>
<dbReference type="CORUM" id="P46527"/>
<dbReference type="DIP" id="DIP-33341N"/>
<dbReference type="IntAct" id="P46527">
<property type="interactions" value="72"/>
</dbReference>
<dbReference type="MINT" id="P46527"/>
<dbReference type="STRING" id="9606.ENSP00000228872"/>
<dbReference type="ChEMBL" id="CHEMBL3758070"/>
<dbReference type="MoonDB" id="P46527">
<property type="type" value="Predicted"/>
</dbReference>
<dbReference type="iPTMnet" id="P46527"/>
<dbReference type="PhosphoSitePlus" id="P46527"/>
<dbReference type="BioMuta" id="CDKN1B"/>
<dbReference type="SWISS-2DPAGE" id="P46527"/>
<dbReference type="CPTAC" id="CPTAC-1237"/>
<dbReference type="CPTAC" id="CPTAC-1238"/>
<dbReference type="EPD" id="P46527"/>
<dbReference type="jPOST" id="P46527"/>
<dbReference type="MassIVE" id="P46527"/>
<dbReference type="PaxDb" id="P46527"/>
<dbReference type="PeptideAtlas" id="P46527"/>
<dbReference type="PRIDE" id="P46527"/>
<dbReference type="ProteomicsDB" id="55741"/>
<dbReference type="TopDownProteomics" id="P46527"/>
<dbReference type="Antibodypedia" id="3295">
<property type="antibodies" value="2612 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="1027"/>
<dbReference type="Ensembl" id="ENST00000228872">
<property type="protein sequence ID" value="ENSP00000228872"/>
<property type="gene ID" value="ENSG00000111276"/>
</dbReference>
<dbReference type="GeneID" id="1027"/>
<dbReference type="KEGG" id="hsa:1027"/>
<dbReference type="CTD" id="1027"/>
<dbReference type="DisGeNET" id="1027"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000111276.10"/>
<dbReference type="GeneCards" id="CDKN1B"/>
<dbReference type="HGNC" id="HGNC:1785">
<property type="gene designation" value="CDKN1B"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000111276">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="CDKN1B"/>
<dbReference type="MIM" id="600778">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="610755">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P46527"/>
<dbReference type="OpenTargets" id="ENSG00000111276"/>
<dbReference type="Orphanet" id="652">
<property type="disease" value="Multiple endocrine neoplasia type 1"/>
</dbReference>
<dbReference type="Orphanet" id="276152">
<property type="disease" value="Multiple endocrine neoplasia type 4"/>
</dbReference>
<dbReference type="PharmGKB" id="PA105"/>
<dbReference type="eggNOG" id="KOG4743">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000159852"/>
<dbReference type="HOGENOM" id="CLU_077692_2_0_1"/>
<dbReference type="InParanoid" id="P46527"/>
<dbReference type="KO" id="K06624"/>
<dbReference type="OMA" id="EGRYEWQ"/>
<dbReference type="OrthoDB" id="1595421at2759"/>
<dbReference type="PhylomeDB" id="P46527"/>
<dbReference type="TreeFam" id="TF101038"/>
<dbReference type="PathwayCommons" id="P46527"/>
<dbReference type="Reactome" id="R-HSA-187577">
<property type="pathway name" value="SCF(Skp2)-mediated degradation of p27/p21"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-198323">
<property type="pathway name" value="AKT phosphorylates targets in the cytosol"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2559582">
<property type="pathway name" value="Senescence-Associated Secretory Phenotype (SASP)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2559586">
<property type="pathway name" value="DNA Damage/Telomere Stress Induced Senescence"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5625900">
<property type="pathway name" value="RHO GTPases activate CIT"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5674400">
<property type="pathway name" value="Constitutive Signaling by AKT1 E17K in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804116">
<property type="pathway name" value="TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69202">
<property type="pathway name" value="Cyclin E associated events during G1/S transition"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69231">
<property type="pathway name" value="Cyclin D associated events in G1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69563">
<property type="pathway name" value="p53-Dependent G1 DNA Damage Response"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69656">
<property type="pathway name" value="Cyclin A:Cdk2-associated events at S phase entry"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8849470">
<property type="pathway name" value="PTK6 Regulates Cell Cycle"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9617828">
<property type="pathway name" value="FOXO-mediated transcription of cell cycle genes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9634638">
<property type="pathway name" value="Estrogen-dependent nuclear events downstream of ESR-membrane signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9661069">
<property type="pathway name" value="Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)"/>
</dbReference>
<dbReference type="SIGNOR" id="P46527"/>
<dbReference type="BioGRID-ORCS" id="1027">
<property type="hits" value="12 hits in 878 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="CDKN1B">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P46527"/>
<dbReference type="GeneWiki" id="CDKN1B"/>
<dbReference type="GenomeRNAi" id="1027"/>
<dbReference type="Pharos" id="P46527">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P46527"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 12"/>
</dbReference>
<dbReference type="RNAct" id="P46527">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000111276">
<property type="expression patterns" value="Expressed in pigmented layer of retina and 253 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P46527">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P46527">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0031464">
<property type="term" value="C:Cul4A-RING E3 ubiquitin ligase complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HGNC-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005768">
<property type="term" value="C:endosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051087">
<property type="term" value="F:chaperone binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0030332">
<property type="term" value="F:cyclin binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0004861">
<property type="term" value="F:cyclin-dependent protein serine/threonine kinase inhibitor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030544">
<property type="term" value="F:Hsp70 protein binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0004860">
<property type="term" value="F:protein kinase inhibitor activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0019903">
<property type="term" value="F:protein phosphatase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0044877">
<property type="term" value="F:protein-containing complex binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0048102">
<property type="term" value="P:autophagic cell death"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007050">
<property type="term" value="P:cell cycle arrest"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="HGNC-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071236">
<property type="term" value="P:cellular response to antibiotic"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071285">
<property type="term" value="P:cellular response to lithium ion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0071407">
<property type="term" value="P:cellular response to organic cyclic compound"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006977">
<property type="term" value="P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000082">
<property type="term" value="P:G1/S transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007507">
<property type="term" value="P:heart development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048839">
<property type="term" value="P:inner ear development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071850">
<property type="term" value="P:mitotic cell cycle arrest"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1905179">
<property type="term" value="P:negative regulation of cardiac muscle tissue regeneration"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045786">
<property type="term" value="P:negative regulation of cell cycle"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030308">
<property type="term" value="P:negative regulation of cell growth"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051271">
<property type="term" value="P:negative regulation of cellular component movement"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1904030">
<property type="term" value="P:negative regulation of cyclin-dependent protein kinase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0045736">
<property type="term" value="P:negative regulation of cyclin-dependent protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060770">
<property type="term" value="P:negative regulation of epithelial cell proliferation involved in prostate gland development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033673">
<property type="term" value="P:negative regulation of kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045930">
<property type="term" value="P:negative regulation of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042326">
<property type="term" value="P:negative regulation of phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904706">
<property type="term" value="P:negative regulation of vascular associated smooth muscle cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007219">
<property type="term" value="P:Notch signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001890">
<property type="term" value="P:placenta development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045787">
<property type="term" value="P:positive regulation of cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0010942">
<property type="term" value="P:positive regulation of cell death"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045737">
<property type="term" value="P:positive regulation of cyclin-dependent protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031116">
<property type="term" value="P:positive regulation of microtubule polymerization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045732">
<property type="term" value="P:positive regulation of protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0006813">
<property type="term" value="P:potassium ion transport"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1902806">
<property type="term" value="P:regulation of cell cycle G1/S phase transition"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000079">
<property type="term" value="P:regulation of cyclin-dependent protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007096">
<property type="term" value="P:regulation of exit from mitosis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1902746">
<property type="term" value="P:regulation of lens fiber cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043200">
<property type="term" value="P:response to amino acid"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046686">
<property type="term" value="P:response to cadmium ion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032355">
<property type="term" value="P:response to estradiol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009749">
<property type="term" value="P:response to glucose"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001666">
<property type="term" value="P:response to hypoxia"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043434">
<property type="term" value="P:response to peptide hormone"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007605">
<property type="term" value="P:sensory perception of sound"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="DisProt" id="DP00018"/>
<dbReference type="IDEAL" id="IID00049"/>
<dbReference type="InterPro" id="IPR003175">
<property type="entry name" value="CDI"/>
</dbReference>
<dbReference type="InterPro" id="IPR029843">
<property type="entry name" value="CDKN1B"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10265:SF9">
<property type="entry name" value="PTHR10265:SF9"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02234">
<property type="entry name" value="CDI"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0967">Endosome</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0649">Protein kinase inhibitor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0043">Tumor suppressor</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Cyclin-dependent kinase inhibitor 1B" id="PRO_0000190084">
<location>
<begin position="1"/>
<end position="198"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with CDK2" evidence="33">
<location>
<begin position="51"/>
<end position="91"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="7">
<location>
<begin position="153"/>
<end position="169"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by UHMK1" evidence="4 9 10 11 15">
<location>
<position position="10"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by SRC" evidence="25">
<location>
<position position="74"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by ABL, LYN, SRC and JAK2" evidence="19 24 25 29">
<location>
<position position="88"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="19">
<location>
<position position="89"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CaMK1, PKB/AKT1 and PIM1" evidence="12 13 26 32">
<location>
<position position="157"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="6">
<location>
<position position="170"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by PKB/AKT1, CDK1 and CDK2" evidence="8 10 20 31">
<location>
<position position="187"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CaMK1, PKB/AKT1, RPS6KA1, RPS6KA3 and PIM1" evidence="10 15 16 26 32">
<location>
<position position="198"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2066828." id="VAR_011871" evidence="36">
<original>R</original>
<variation>W</variation>
<location>
<position position="15"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with multiple endocrine tumors; germline mutation; reduced expression levels; shows impaired binding to CDK2; dbSNP:rs777354267." id="VAR_064429" evidence="28">
<original>P</original>
<variation>L</variation>
<location>
<position position="69"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2066827." id="VAR_011872" evidence="17 35 36">
<original>V</original>
<variation>G</variation>
<location>
<position position="109"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation by UHMK1. No translocation to the cytoplasm. Greater cell cycle arrest." evidence="10 11 16">
<original>S</original>
<variation>A</variation>
<location>
<position position="10"/>
</location>
</feature>
<feature type="mutagenesis site" description="Exported to the cytoplasm. Inhibits cell cycle arrest." evidence="10 11 16">
<original>S</original>
<variation>D</variation>
<location>
<position position="10"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased stability in vivo and in vitro." evidence="10 11 16">
<original>S</original>
<variation>E</variation>
<location>
<position position="10"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in binding CDK4 and no inhibition of CDK4 activity. Translocates to nucleus. No effect on in vitro phosphorylation of CDK4 by CCNH-CDK7." evidence="19 27">
<original>Y</original>
<variation>F</variation>
<location>
<position position="74"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes LYN-mediated phosphorylation, reduces CDK2-mediated phosphorylation on T-187, has greater cell cycle arrest into S-phase, no effect on binding CDK2 complexes, reduced CDK4 binding and inhibits CDK4 enzyme activity. No nuclear translocation. No effect on in vitro phosphorylation of CDK4 by CCNH-CDK7. Completely abolishes CDK4 binding; when associated with F-89." evidence="19 24 27">
<original>Y</original>
<variation>F</variation>
<location>
<position position="88"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on binding CDK2 complexes, reduced CDK4 binding and greatly inhibits CDK4 enzyme activity. No nuclear translocation. Inhibits in vitro phosphorylation of CDK4 by CCNH-CDK7. Completely abolishes CDK4 binding; when associated with F-88." evidence="19 24 27">
<original>Y</original>
<variation>F</variation>
<location>
<position position="89"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly reduced PKB/AKT1-mediated phosphorylation. Nuclear location. Inhibits cyclin E/CDK2 cell cycle progression. No effect on binding AKT1. Completely abolishes PKB/AKT1-mediated phosphorylation and no cytoplasmic translocation; when associated with A-198." evidence="10 12 13 15 16">
<original>T</original>
<variation>A</variation>
<location>
<position position="157"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in PKB/AKT1-mediated phosphorylation." evidence="12">
<original>S</original>
<variation>A</variation>
<location>
<position position="161"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in PKB/AKT1-mediated phosphorylation." evidence="12">
<original>T</original>
<variation>A</variation>
<location>
<position position="162"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced ubiquitination by a TRIM21-containing SCF(SKP2) complex." evidence="20">
<original>E</original>
<variation>A</variation>
<variation>D</variation>
<variation>Q</variation>
<location>
<position position="185"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in PKB/AKT1- nor UHMK1-mediated phosphorylation." evidence="10 11 16 20 22">
<original>T</original>
<variation>A</variation>
<variation>D</variation>
<location>
<position position="187"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation-dependent ubiquitination." evidence="10 11 16 20 22">
<original>T</original>
<variation>A</variation>
<location>
<position position="187"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes PKB/AKT1-mediated phosphorylation. 46% cytoplasmic location. Greatly reduced binding to YWHAQ. Equally reduced binding; when associated with A-10 and A-187. No nuclear import; when associated with A-157. Completely abolishes PKB/AKT1-mediated phosphorylation and no cytoplasmic translocation; when associated with A-157." evidence="10 15 16">
<original>T</original>
<variation>A</variation>
<variation>D</variation>
<location>
<position position="198"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAD14244." ref="2" evidence="39">
<original>E</original>
<variation>D</variation>
<location>
<position position="22"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="38"/>
<end position="47"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="50"/>
<end position="53"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="55"/>
<end position="60"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="64"/>
<end position="67"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="71"/>
<end position="78"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="86"/>
<end position="89"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1JSU"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5UQ3"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6ATH"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000250"/>
<evidence key="6" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P46414"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255"/>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10323868"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10831586"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12042314"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12093740"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12244301"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12244303"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12972555"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14504289"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15280662"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16007079"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16195327"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16209941"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16782892"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16880511"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17030811"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17254966"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17254967"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18593906"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19075005"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20824794"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21423214"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22586611"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23478441"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23707388"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28666995"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8684460"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="36" type="ECO:0000269">
<source ref="4"/>
</evidence>
<evidence key="37" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="28666995"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8033212"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000305"/>
<sequence length="198" mass="22073" checksum="1118D58901CDF3FC" modified="1995-11-01" version="1">MSNVRVSNGSPSLERMDARQAEHPKPSACRNLFGPVDHEELTRDLEKHCRDMEEASQRKWNFDFQNHKPLEGKYEWQEVEKGSLPEFYYRPPRPPKGACKVPAQESQDVSGSRPAAPLIGAPANSEDTHLVDPKTDPSDSQTGLAEQCAGIRKRPATDDSSTQNKRANRTEENVSDGSPNAGSVEQTPKKPGLRRRQT</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

